Piribo: New publication announcement, Pharmaceutical Licensing Strategies

August 20, 2006 (PRLEAP.COM) Health News
With falling R&D productivity and continued healthcare cost containment and generic competition pushing down the returns available for successfully launched products, only those companies able to complement internal efforts with a strong partnering strategy will be able to remain competitive over the next five-to-ten years. Pharmaceutical licensing strategies: Best practices in deal-making, valuations and strategic management provides a detailed analysis of licensing strategies in the pharmaceutical and biotechnology industries. The report draws upon deal-making trend data, primary research survey results and a profile of best practices in pharmaceutical licensing in order to present a set of actionable recommendations for optimizing deal-making. "The global pharmaceutical market with sales of approximately $550 billion is about to enter a pivotal period in its history. The industry has been used to double digit growth rates but growth has now dropped to below 10% for the first time. In addition to this whole swathes of lucrative high revenue earning drugs are going to lose patent.

Contents
Chapter 1 Executive Summary
Chapter 2 Introduction And Epidemiology
Chapter 3 Current Treatment
Chapter 4 Assessment And Clinical Trial Design
Chapter 5 Increasing Sle Market Opportunities
Chapter 6 Pipeline Drugs And Key Trials

“Pharmaceutical Licensing Strategies - Best practices in deal-making, valuations and strategic management” is available from Piribo. For more information go to: http://www.piribo.com/publications/diseases_conditions/stakeholder_opinions_systemic_lupus_erythematosus.html

Piribo Product ID: RBI077

About Piribo.
Piribo (http://www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,800 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.